Fuhong Hanlin: The first patient in China to receive treatment with HLX701 in combination with cetuximab and chemotherapy for advanced colorectal cancer in a phase 1b/2 clinical study.

(Fosun Pharma) announced that recently, the first patient in China received treatment with HLX701 in combination with cetuximab and chemotherapy for the 1b/2 phase clinical study of advanced colorectal cancer.